דף הבית

פרסום המאמר באתרך

באפשרותך לפרסם את המאמר הזה באתרך בכפוף לתנאי השימוש .בפרסום המאמר עליך להקפיד על הכללים הבאים: יש לפרסם את כותרת המאמר, תוכנו, וכן פרטים אודות כותב המאמר. כמו כן יש לכלול קישור לאתר מאמרים עסקיים ומקצועיים (http://www.portal-asakim.com).

בחזרה למאמר

כותרת המאמר:


תקציר המאמר:
ZOLL® Medical Corporation, חברה של Asahi Kasei המייצרת מכשור רפואי ופתרונות תוכנה נלווים, הודיעה היום כי השלימה בהצלחה את הרכישה שהוכרזה בעבר של איתמר מדיקל בע"מ, חברת מכשור רפואי ובריאות דיגיטלית המספקת בדיקות ביתיות לדום נשימה בשינה.

מילות מפתח:


קישור ישיר למאמר:


גירסת HTML:
<html> <head> <title>ZOLL מודיעה על השלמת רכישת איתמר מדיקל</title> <meta name="description" content="ZOLL® Medical Corporation, חברה של Asahi Kasei המייצרת מכשור רפואי ופתרונות תוכנה נלווים, הודיעה היום כי השלימה בהצלחה את הרכישה שהוכרזה בעבר של איתמר מדיקל בע"מ, חברת מכשור רפואי ובריאות דיגיטלית המספקת בדיקות ביתיות לדום נשימה בשינה."> <meta name="keywords" content="BUSINESS WIRE,נוי תקשורת"> <meta name="expires" CONTENT="never"> <meta name="language" CONTENT="hebrew"> <meta name="distribution" CONTENT="Global"> <meta name="robots" content="index, follow"> <meta http-equiv="Content-Type" content="text/html; charset=windows-1255"> </title> <body dir="rtl"> <h1>ZOLL מודיעה על השלמת רכישת איתמר מדיקל</h1><br/> <br/><strong>נכתב על ידי: <a title="ZOLL מודיעה על השלמת רכישת איתמר מדיקל" href="http://www.portal-asakim.com/Authors//Author576.aspx ">חיים נוי</a></strong><br/> <br/><p align="center"><strong>ZOLL</strong><strong> מודיעה על השלמת</strong><strong> רכישת איתמר מדיקל</strong><strong></strong></p> <p><strong> </strong></p> <p>ZOLL<sup>®</sup> Medical Corporation, חברה של Asahi Kaseiהמייצרת מכשור רפואי ופתרונות תוכנה נלווים, הודיעה היום כי השלימה בהצלחה את הרכישה שהוכרזה בעבר של איתמר מדיקל בע"מ, חברת מכשור רפואי ובריאות דיגיטלית המספקת בדיקות ביתיות לדום נשימה בשינה.</p> <p align="center"><strong>ZOLL Announces Closing of Acquisition of Itamar Medical</strong><strong></strong></p> <p>CHELMSFORD, Mass., 16 December 16, 2021, (<a href="http://www.businesswire.com/">BUSINESS WIRE</a>):</p> <p><a name="_Hlk90549826">ZOLL<sup>®</sup> Medical Corporation</a>, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has successfully completed its previously announced acquisition of Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR) ("Itamar Medical"), a medical device and digital health company that provides at-home testing for sleep apnea.</p> <p>"We are pleased to announce the closing of the acquisition of Itamar and welcome its employees to the ZOLL family," said Jon Rennert, ZOLL CEO. "Together, ZOLL and Itamar Medical will help more patients receive diagnosis and treatment for sleep-disordered breathing and help strengthen the collaboration between the worlds of cardiology and sleep medicine."</p> <p>Itamar Medical will operate as a business division within ZOLL, and Gilad Glick, who previously served as Itamar Medical’s CEO, will lead the division as its President. Itamar Medical’s principal operations in Caesarea, Israel will continue with no material changes to operations currently anticipated. Moving forward, ZOLL will focus on the continuity of Itamar Medical’s business while using ZOLL’s global infrastructure and strong brand to accelerate and expand growth opportunities.</p> <p><strong>Transaction Details</strong></p> <p>ZOLL acquired all outstanding ordinary shares of Itamar Medical for $1.0333333 (equivalent to approximately NIS 3.24) per ordinary share, or $31 per American Depository Share (ADS), in cash (without interest, less any applicable withholding taxes and, in the case of ADSs, less applicable cancellation fees).</p> <p>As a result, Itamar Medical’s ordinary shares will cease to be traded on the TASE market and Itamar Medical will no longer have reporting obligations under applicable Israeli securities laws.</p> <p>In addition, Itamar Medical has requested that trading of its ADSs on the Nasdaq Capital Market (Nasdaq) be terminated and further that Nasdaq file a Form 25 with the U.S. Securities and Exchange Commission (SEC) notifying the SEC of the delisting of its ADSs on the Nasdaq and the deregistration of Itamar Medical’s registered securities.</p> <p>Itamar Medical intends to promptly file with the SEC a Post-Effective Amendment to Form F-3 Registration Statement and Post-Effective Amendment to Form S-8 Registration Statement to deregister Itamar Medical’s unsold securities that are currently registered pursuant to Form F-3 and Form S-8, respectively. Thereafter, Itamar Medical intends to terminate its reporting obligations under the Securities Exchange Act of 1934, as amended (Exchange Act), by promptly filing a Form 15 with the SEC. Itamar Medical’s obligation to file with the SEC certain reports and forms, including Form 20-F and Form 6-K, will be suspended immediately as of the filing date of the Form 15 and will terminate once the deregistration becomes effective.</p> <p><strong>Advisors</strong></p> <p>Goldman Sachs & Co. LLC acted as financial advisor to ZOLL, and Cooley LLP and Gornitzky & Co. served as legal advisors to ZOLL for the transaction. Piper Sandler & Co. acted as financial advisor to Itamar Medical, and Latham & Watkins LLP and Goldfarb Seligman & Co. acted as its legal advisors.</p> <p><strong>About ZOLL</strong></p> <p>ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zoll.com%2F&esheet=52551712&lan=en-US&anchor=www.zoll.com&index=1&md5=eeeef0f773edee3ce65db14fe51d0f8d">www.zoll.com</a>.</p> <p><strong>About Asahi Kasei</strong></p> <p>The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 40,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. For more information, visit <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.asahi-kasei.com%2F&esheet=52551712&lan=en-US&anchor=www.asahi-kasei.com&index=2&md5=972861d4706787015b22558a16ec5463">www.asahi-kasei.com</a>.</p> <p><strong>About Itamar Medical Ltd.</strong></p> <p>Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the U.S., Japan, and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.itamar-medical.com%2F&esheet=52551712&lan=en-US&anchor=www.itamar-medical.com&index=3&md5=d8e924ab56605d96a3a229a3a6940604">www.itamar-medical.com</a>.</p> <p>Contacts</p> <p><strong>Media Contact:</strong><br /> Matt Hogan<br /> ZOLL Medical Corporation<br /> 978-805-6561<br /> media@zoll.com</p> <p>Source: ZOLL Medical Corporation</p> <p><strong>תוכן הודעה זו בשפת המקור, מהווה את הגרסה הרשמית והמהימנה היחידה של מסמך זה. תרגומים מסופקים למטרות נוחות בלבד ויש להצליבם מול המסמך בשפת המקור, המהווה את הגרסה היחידה של טקסט זה שהינה בעלת תוקף משפטי.</strong></p> <p>*** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית BUSINESS WIRE</p> <br/><br/> <strong><u>פרטים אודות כותב המאמר</u></strong> <br/> <p><strong>חיים נוי, עיתונאי, עורך ראשי של סוכנות החדשות הבינ"ל IPA, לשעבר עורך ראשי של סוכנות הידיעות עתים, חבר תא מבקרי התיאטרון באגודת העיתונאים</strong></p> <br/><a href="http://www.portal-asakim.com"> מקור המאמר: אתר מאמרים עסקיים ומקצועיים</a>

גירסת טקסט:
ZOLL מודיעה על השלמת רכישת איתמר מדיקל ZOLL מודיעה על השלמת רכישת איתמר מדיקל ZOLL® Medical Corporation, חברה של Asahi Kaseiהמייצרת מכשור רפואי ופתרונות תוכנה נלווים, הודיעה היום כי השלימה בהצלחה את הרכישה שהוכרזה בעבר של איתמר מדיקל בע"מ, חברת מכשור רפואי ובריאות דיגיטלית המספקת בדיקות ביתיות לדום נשימה בשינה. ZOLL Announces Closing of Acquisition of Itamar Medical CHELMSFORD, Mass., 16 December 16, 2021, (BUSINESS WIRE): ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has successfully completed its previously announced acquisition of Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR) ("Itamar Medical"), a medical device and digital health company that provides at-home testing for sleep apnea. "We are pleased to announce the closing of the acquisition of Itamar and welcome its employees to the ZOLL family," said Jon Rennert, ZOLL CEO. "Together, ZOLL and Itamar Medical will help more patients receive diagnosis and treatment for sleep-disordered breathing and help strengthen the collaboration between the worlds of cardiology and sleep medicine." Itamar Medical will operate as a business division within ZOLL, and Gilad Glick, who previously served as Itamar Medical’s CEO, will lead the division as its President. Itamar Medical’s principal operations in Caesarea, Israel will continue with no material changes to operations currently anticipated. Moving forward, ZOLL will focus on the continuity of Itamar Medical’s business while using ZOLL’s global infrastructure and strong brand to accelerate and expand growth opportunities. Transaction Details ZOLL acquired all outstanding ordinary shares of Itamar Medical for $1.0333333 (equivalent to approximately NIS 3.24) per ordinary share, or $31 per American Depository Share (ADS), in cash (without interest, less any applicable withholding taxes and, in the case of ADSs, less applicable cancellation fees). As a result, Itamar Medical’s ordinary shares will cease to be traded on the TASE market and Itamar Medical will no longer have reporting obligations under applicable Israeli securities laws. In addition, Itamar Medical has requested that trading of its ADSs on the Nasdaq Capital Market (Nasdaq) be terminated and further that Nasdaq file a Form 25 with the U.S. Securities and Exchange Commission (SEC) notifying the SEC of the delisting of its ADSs on the Nasdaq and the deregistration of Itamar Medical’s registered securities. Itamar Medical intends to promptly file with the SEC a Post-Effective Amendment to Form F-3 Registration Statement and Post-Effective Amendment to Form S-8 Registration Statement to deregister Itamar Medical’s unsold securities that are currently registered pursuant to Form F-3 and Form S-8, respectively. Thereafter, Itamar Medical intends to terminate its reporting obligations under the Securities Exchange Act of 1934, as amended (Exchange Act), by promptly filing a Form 15 with the SEC. Itamar Medical’s obligation to file with the SEC certain reports and forms, including Form 20-F and Form 6-K, will be suspended immediately as of the filing date of the Form 15 and will terminate once the deregistration becomes effective. Advisors Goldman Sachs & Co. LLC acted as financial advisor to ZOLL, and Cooley LLP and Gornitzky & Co. served as legal advisors to ZOLL for the transaction. Piper Sandler & Co. acted as financial advisor to Itamar Medical, and Latham & Watkins LLP and Goldfarb Seligman & Co. acted as its legal advisors. About ZOLL ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com. About Asahi Kasei The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 40,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. For more information, visit www.asahi-kasei.com. About Itamar Medical Ltd. Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the U.S., Japan, and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com. Contacts Media Contact: Matt Hogan ZOLL Medical Corporation 978-805-6561 media@zoll.com Source: ZOLL Medical Corporation תוכן הודעה זו בשפת המקור, מהווה את הגרסה הרשמית והמהימנה היחידה של מסמך זה. תרגומים מסופקים למטרות נוחות בלבד ויש להצליבם מול המסמך בשפת המקור, המהווה את הגרסה היחידה של טקסט זה שהינה בעלת תוקף משפטי. *** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית BUSINESS WIRE נכתב על ידי חיים נוי, עיתונאי, עורך ראשי של סוכנות החדשות הבינ"ל IPA, לשעבר עורך ראשי של סוכנות הידיעות עתים, חבר תא מבקרי התיאטרון באגודת העיתונאים מקור המאמר:אתר מאמרים עסקיים ומקצועיים http://www.portal-asakim.com
בחזרה למאמר

לכותבי מאמרים

התחבר הרשמה למערכת שחזור סיסמה

מאמרים בקטגוריות
אימון אישי
אינטרנט והחיים ברשת
בידור ופנאי
ביטוח
בית משפחה וזוגיות
בניין ואחזקה
הודעות לעיתונות
חברה, פוליטיקה ומדינה
חוק ומשפט
חינוך ולימודים
מדעי החברה
מדעי הטבע
מדעי הרוח
מחשבים וטכנולוגיה
מיסים
מתכונים ואוכל
נשים
ספורט וכושר גופני
עבודה וקריירה
עיצוב ואדריכלות
עסקים
פיננסים וכספים
קניות וצרכנות
רוחניות
רפואה ובריאות
תחבורה ורכב
תיירות ונופש

שיווק באינטרנט על ידי WSI